Life-sciences company Cambrex Corporation (CBM) provides various products and services for the development and commercialization of new and generic therapeutics. It's primarily involved in the custom development and manufacture of pharmaceutical ingredients derived from organic chemistry.
The company’s products include active pharmaceutical ingredients (APIs) and intermediates, generic and branded APIs, controlled substances, chiral compounds, high potency and technology-enhanced APIs along with fine chemicals.
IBD Industry Rank; 21
- EPS percent change last quarter; +106%
- Last three quarters average EPS growth; +67%
- Sales +13%
- Six quarters of increasing fund ownership
The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.